Introduction {#sec1-1}
============

Acute liver injury (ALI), is a clinical state that results from severe and extensive damage of liver tissue with reduced cell mass and blood flow. It is associated with an increase in serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALT), and total serum bilirubin (TSB) \[[@ref1]\], \[[@ref2]\], \[[@ref3]\].

It is a serious condition caused by different agents toxins, drug intoxication, and other factors \[[@ref4]\], \[[@ref5]\]. It is characterised by rapid deterioration of the liver cells function, resulting in hepatic encephalopathy & coagulopathy in the liver of normal subjects \[[@ref6]\].

Carbon tetrachloride (CCL4), is a famous hepatotoxic agent that used orally or intraperitoneally in animals (especially in rodents) for the induction of ALI due to the formation of free radicals mediated lipid peroxidation \[[@ref7]\].

Carbon tetrachloride (CCL4) is a well-known hepato-toxicant via causing oxidative stress-mediated liver injury and has a similar mechanism in animals and humans \[[@ref8]\].

CCL4 toxicity results from its bioactivation to the highly toxic reactive trichloromethyl peroxyl radical that subsequently attack the polyunsaturated fatty acids of cell membranes to propagate a chain reaction resulting in peroxidative decomposition of cytoplasmic membrane lipids \[[@ref9]\], leading to progression of liver damage with subsequent hepatocellular carcinoma \[[@ref10]\].

A single dose of CCL4 causes centrizonal necrosis and steatosis \[[@ref11]\], while prolonged administration causes liver fibrosis, cirrhosis, and hepatocellular carcinoma \[[@ref12]\]. CCL4 affects hepatocytes directly by altering the permeability of the plasma, mitochondrial, and lysosomal membranes. Highly reactive free radicals are also produced by the mixed function oxidase system of CYP2E1 in hepatocytes, causing severe centrilobular necrosis \[[@ref13]\], \[[@ref14]\]. This model has been used extensively to examine the pathogenesis of cirrhosis. Liver fibrosis is the pathologic result of ongoing chronic inflammatory liver diseases that is characterised by hepatic stellate cell (HSC) proliferation and differentiation to myofibroblast-like cells, which deposit collagen and extracellular matrix \[[@ref15]\].

Several familiar drugs had been proved in having hepatoprotective activity against CCL4 induced model of ALI \[[@ref16]\]. It is interesting to explore the possible hepatoprotective effect of Nitroglycerin, N-acetyl cysteine and Metoprolol Tartrate in the current study.

Material and Methods {#sec1-2}
====================

Chemicals {#sec2-1}
---------

All chemicals used are of analytic grades. CCL4 was supplied by Merck-Germany as a pause liquid. Nitroglycerin by Amrit medical center-Syria, N-acetyl cysteine powder from Cimex AG Ltd-Switzerland, Metoprolol tartrate from Al Parma, Barn- staple. The UK. The kits for the estimation of ALP, AST, ALT was purchased from BioMérieux- France while that for TSB & TSP from Randox-England.

Animals {#sec2-2}
-------

Thirty-five healthy domestic rabbits weighing 700-800 gm were used in the present study. They were supplied by the animal house of Pharmacy College. Animals were housed in separated cages under good conditions of 28°C with 12 hrs of the light/dark cycle. They were fed standard oxoid pellets and were given water ad libitum.

The study was conducted according to the animal ethics committee of Al-Nahrain College of Medicine (approval number: 2016/24156). The rabbits were normally allocated to five groups. They were given a single daily dose of the following drugs for five successive days at 8.00 am.

Group-1: (control), received 3 ml of distilled water orally and without CCL4 administration.

*Group-2:* (drug control), received 3 ml of distilled water orally.

*Group-3:* received Nitroglycerin 1 mg/kg orally.

*Group-4:* received N-acetyl cysteine 275 mg/kg orally.

*Group-5:* received Metoprolol 7 mg/kg orally.

The doses of Nitroglycerin, N-acetyl cysteine and Metoprolol tartrate had been chosen after many trials in a pilot study.

At 9.00 a.m. on the first day, CCL4 was given to animals of groups 2, 3, 4 and 5 in a dose of 1 mg/kg orally for induction of ALI. Blood samples were collected from marginal ear vein of the rabbits of all groups for biochemical analysis of serum AST, ALT, ALP, TSB and TSP at three occasions, 24, 72, 120 hrs using spectrophotometer method \[[@ref17]\] for comparison between the value of these results.

Later on, all the rabbits were sacrificed under light anaesthesia of Diethyl ether (ether) to take specimens of the liver. The histopathological examination was carried out to check the microscopic changes in the liver tissue, using a polarised microscope after fixating the sections in 10% formalin for 48 hrs & staining with hematoxylin & eosin \[[@ref18]\].

Statistical analysis {#sec2-3}
--------------------

The obtained results were expressed as means ± SEM. The difference among means has been analysed by students t-test using SPSS version 12. P values \< 0.05 were considered to be significant.

Results {#sec1-3}
=======

Administration of CCL4 to the rabbits in the group -2 produced a marked increase in serum AST, ALT, ALP &TSB levels with a decrease in TSP level compared with normal control (group-1). Both nitroglycerine (group-3) & N-acetylcysteine (group-4) revealed significant reduction in serum ALP, AST, ALT & TSB levels with significant elevation of TSP level when compared with the control (group-2) & their levels at 24, 72, 120 hrs. N-acetyl cysteine (NAC) was more potent than nitroglycerine in improving hepatic function test significantly especially ALT, AST & TSP with values 30.17 ± 3.46, 29.67 ± 3.51 and 30.83 ± 2.41 and 5.03 ± 0.16 respectively for nitroglycerin while nitroglycerin was more potent in changing ALP and TSB significantly than NAC with values 44.45 ± 3.3, 11.3 ± 0.28 respectively versus 48.17 ± 4.05, 11.6 ± 0.21 for NAC respectively measured at 120 hr. Metoprolol showed a significant decrease of AST at different occasions in comparison with the drug control while serum ALT, ALP levels significantly decreased at 24 hr p \< 0.05 in comparison with 72, and 120 hr.

###### 

Serum levels of ALT, AST, ALP with TSB & TSP of tested drugs: nitroglycerine, NAC, metoprolol tartrate after induction of ALI by CCL4 measured at 24, 72 & 120 hrs

  Group                 Dose            Duration (hr)   S. ALT U/L     S. AST U/L     S. ALP U/L     TSB Umol/ L   TSP g/dl
  --------------------- --------------- --------------- -------------- -------------- -------------- ------------- ------------
  Normal control                                        23.72±0.94     23.38±1.38     49.03±3.23     11.27±0.61    5.58±0.11
                                                                                                                   
  CCL4 alone            1ml/Kg          24hr            133.32±2.72a   208.45±3.73a   206.35±3.3a    30.57±1.21a   4.3±0.23a
                                                                                                                   
  72hr                  115.12±4.76 b   194.38±5.15 a   204.05±4.25a   26.70±1.57ab   4.60±0.17a                   
                                                                                                                   
  120hr                 97.83±3.97b     146.52±6.15b    189.98±5.21a   20.13±1.56a    4.58±0.16a                   
                                                                                                                   
  Nitro-glycerine       1ml/Kg          24hr            92.17±1.17a    144.17±2.21a   126.83±2.80a   14.38±0.35a   4.45±0.57a
                                                                                                                   
  72hr                  78.50±4.02b     108.50±6.84b    44±3.87b       13.38±0.25b    5.03±0.08b                   
                                                                                                                   
  120hr                 40.42±3.10c     30.83±2.41c     44.45±3.30b    11.30±0.28c    5.03±0.16b                   
                                                                                                                   
  N-acetyl cysteine     275mg/kg        24hr            82.17±4.47a    118.17±4.94a   109.17±7.35a   13.73±0.40a   4.85±0.89a
                                                                                                                   
  72hr                  65.67±2.62b     84.67±4.41b     62.83±4.05b    11.77±0.30b    5.12±0.79ab                  
                                                                                                                   
  120hr                 30.17±3.46c     29.67±3.51c     48.17±4.05c    11.60±0.31b    5.28±0.13b                   
                                                                                                                   
  Metoprolol tartrate   7mg/kg          24hr            84.76±4.70a    102.53±2.12a   132.78±7.71a   13.62±0.68a   4.70±0.97a
                                                                                                                   
  72hr                  64.47±2.90b     93.87±1.83b     105.77±3.48b   12.30±0.38a    4.87±0.72a                   
                                                                                                                   
  120hr                 64.40±2.27b     85.70±2.45c     96.30±4b       11.58±0.49a    4.83±0.13a                   

Same letters mean non-significant lowering effect at (P\> 0.05); -Different letters mean significant lowering effect at (P\< 0.05).

Histopathological studies of liver sections supported the results obtained from serum enzymes assays, which demonstrated the normal architecture in rabbits of Group-1 ([Figure 1](#F1){ref-type="fig"}).

![Normal rabbit liver section showing hepatocyte architecture with normal lobular appearance (40X, H&E stain)](OAMJMS-7-1739-g001){#F1}

Whereas the liver sections of rabbits in group-2 showed a total loss of hepatic architecture with massive fatty changes, intense necrosis, congestion and infiltration of the lymphocytes around the central vein ([Figure 2](#F2){ref-type="fig"}).

![Liver section after administration of CCL4 showing massive necrosis, fatty changes, congestion and lymphocyte infiltration (40X, H&E stain)](OAMJMS-7-1739-g002){#F2}

The liver sections in rabbits of Group 3, 4 and 5 showed a more or less normal lobular pattern with a mild degree of congestion, fatty changes and mild lymphocytes infiltration with minimal necrosis or no necrosis indicating the hepatoprotective effect of nitroglycerin NAC & metoprolol tartrate (Figures [3A](#F3){ref-type="fig"}, [3B](#F3){ref-type="fig"}, and [3C](#F3){ref-type="fig"}).

![3A) Liver section after CCL4 and nitroglycerine administration showing mild to moderate fatty changes, congestion & minimal necrosis (40X, H&E stain); 3B) Liver section after CCL4 and N-acetyl cysteine administration showing very minimal fatty changes with congestion and minimal necrosis (40X, H&E stain); 3C) Liver section after CCL4 and metoprolol tartrate administration showing severe fatty changes, mild congestion with multifocal hepatocellular necrosis (40X, H&E stain)](OAMJMS-7-1739-g003){#F3}

Discussion {#sec1-4}
==========

The hepatotoxicity of CCL4 is well known for the induction of ALI in the experimental animal model. CCL4 is biotransformed in the cytochrome P-450 system to its metabolite trichloro-methyl free radical (ccl3) which in the presence of O~2~ forms trichloro- methyl-peroxyl free radical (ccl~3~O~2~ that attacks lipid of endoplasmic reticulum, eliciting lipid peroxidation with the leakage of hepatocellular enzymes AST, ALT and ALP in the serum causing a significant increase in TSB and a decrease in TSP \[[@ref18]\]. The results of the drug control (Group-2) in the current study are compatible with the results of others \[[@ref19]\], \[[@ref20]\] who demonstrated that changes of CCL4 at day one might correspond to liver intoxication then the changes decrease at day four due to the normal physiology of liver regeneration \[[@ref21]\].

Administration of nitroglycerin, which is an effective vasodilator drug in the treatment of angina pectoris (Group-3) produced significant positive results in improving ALI induced by CCL4. The results were more evident when given in a dose-dependent manner \[[@ref22]\]. Nitroglycerin is a member of organic nitrate with antioxidant activity \[[@ref23]\]. It causes the release of nitric oxide (NO), thus the hepatoprotective effect of the drug attributed to the effect of NO inactivation of guanylyl cyclase leading to the synthesis of CAMP (T3) \[[@ref24]\]. Nitric oxide proved in having antiapoptotic activity in the hepatocytes. It has been shown in the following study to ameliorate the rise of ALT, AST and improve the histopathological changes that were induced by CCL4 administration \[[@ref25]\], \[[@ref26]\].

N-acetyl cysteine (NAC) is a mucolytic agent that reduces the viscosity of secretions & used in paracetamol poisoning (Group-4) \[[@ref27]\]. NAC has an antioxidant and anti-inflammatory effect \[[@ref28]\] when used in vivo & in vitro. It is a source of sulfhydryl group that indirectly increase GSH supply for glutathione peroxidase & directly reacts with reactive oxygen species \[[@ref29]\].

The results of NAC in the current study were similar to the results of others \[[@ref30]\] who used NAC against liver damage induced by methotrexate causing a decrease in GSH level & superoxide dismutase and catalase activity & increase in malondialdehyde level. Moreover, N-acetyl cysteine has been shown in previous studies to improve the paracetamol and phenacetin induced hepatic and blood, biochemical, and histopathological disturbances. It has an antioxidant and hepatoprotective efficacy against the drug-induced liver injury \[[@ref31]\].

Metoprolol tartrate is a selective B1 adrenoceptor blocking drug (Group-5) produces a negative chronotropic & inotropic effect and can lower HDL level used in prophylaxis of hypertension and angina pectoris \[[@ref32]\]. The antioxidant effect of metoprolol in vitro has been studied and described previously \[[@ref1]\]. The antioxidant properties of metoprolol in vivo are a little bit query as there is only one study showing a little hepatoprotective effect \[[@ref2]\]. Many drugs with putative antioxidant effects require high concentration or show antioxidant effects only under in vitro conditions. Thus, the real contribution of the putative antioxidant effects of metoprolol to its efficacy as a hepatoprotective agent was explored in our study. This is a very important issue because this may provide a valuable contribution for the final healing outcome.

In conclusion, nitroglycerine, N-acetyl cysteine & metoprolol tartrate had proved in having a hepatoprotective effect by increasing the normal hepatic function & enhancing the biodefense of the liver tissue against the oxidative damage produced by CCL4 administration.
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